STACEY HARVEY: Open Payments
NPI 1467140038 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,253 in 54 payments from 14 companies in 2025. Trend: 2023 $450 · 2024 $1,333 · 2025 $1,253
Food & beverage: $1,253
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $320 |
| Alkermes, Inc. | 9 | $211 |
| Axsome Therapeutics, Inc. | 4 | $98 |
| Janssen Pharmaceuticals, Inc | 4 | $96 |
| Teva Pharmaceuticals USA, Inc. | 4 | $82 |
| Vanda Pharmaceuticals Inc. | 3 | $76 |
| Lundbeck LLC | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Braeburn Inc. | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
Products named: VRAYLAR, ARISTADA, REXULTI, Auvelity, FANAPT, INVEGA SUSTENNA, BRIXADI, CAPLYTA.
Industry payments across CO — which companies pay providers there.
